Dr. Jeffry Brian Lawrence, M.D. Pathology - Hematology Medicare: Not Enrolled in Medicare Practice Location: 3 Pond View Rd, Chester, NJ 07930 Phone: 908-879-4241 Fax: 508-478-1883 |
News Archive
"New federal standards unveiled last month require doctors to start using electronic medical records routinely, including logging patients' diagnoses and visits, ordering prescriptions, monitoring for drug interactions and making records accessible to other medical providers. ... Only about 20 percent of South Florida medical providers use electronic records now, experts said, and while many doctors are already making the change, some fear that older family physicians may one day close their practices rather than spend the money and time to go digital"
The ORBERA Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.
About 11 million people - roughly 1-in-25 Americans - are now believed to be affected by one or more food allergies, a disease triggered by the ingestion or contact with certain foods that may cause life-threatening reactions, or anaphylaxis, according to a recent Food Allergy & Anaphylaxis Network nationwide survey.
A rigorous, new scientific Systematic Review paper on caffeine safety confirms the results of the widely-cited Health Canada literature review (2003), which concluded that adverse health effects were not associated with caffeine intake levels at ≤400 mg/day for adults (which is the equivalent of about 4 cups of coffee/day, and 90% of Americans typically consume less than this amount, ≤300 mg/day for pregnant women and ≤2.5 mg/kg-day for children and adolescents.
Hi-Tech Pharmacal Co., Inc. announced today that it received clearance from the FDA to market Tropazone™ lotion, a prescription dermatological product which will be promoted by Hi-Tech's branded marketing subsidiary, ECR Pharmaceuticals Co., Inc. The product is indicated for the treatment of various dermatological conditions including atopic dermatitis, allergic contact dermatitis, and radiation dermatitis.
› Verified 3 days ago